Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Adi Zuloff-Shani
Person

Adi Zuloff-Shani

Tracked across 3 events · 19 articles · First seen Jun 18, 2026 · Last active Aug 13, 2026

Sentiment
20
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 60
Business
Clearmind DSMB Approves CMND-100 Trial Advancement
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotech company, announced that its independent Data and Safety Monitoring Board (DSMB) unanimously approved advancing its FDA-regulated Phase I/II clinical trial of CMND-100, a non-hallucinogenic neuroplastogen-derived candidate for…
Impact: As CEO, Dr. Zuloff-Shani is the public face of the announcement and her leadership is central to the company's strategic progress.
Aug 06, 2026 · 6 articles
4 0
Business
Clearmind Medicine Secures US Patents
Impact: Adi Zuloff-Shani, CEO of Clearmind Medicine, commented on the significance of the patent grants, highlighting their role in advancing clinical programs and reinforcing the company's leadership in psychedelic-based therapies.
Jun 18, 2026 · 7 articles
2 0
Business
NeuroThera initiates Phase IIb Tourette trial
Impact: Dr. Adi Zuloff-Shani is the Chief Technology Officer of NeuroThera and commented on the trial initiation, but has no direct financial stake.
Jul 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Adi Zuloff-Shani live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.